<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01368601</url>
  </required_header>
  <id_info>
    <org_study_id>INFLATOR</org_study_id>
    <nct_id>NCT01368601</nct_id>
  </id_info>
  <brief_title>Effects of Intraoperative Continuous Airway Pressure (CPAP) on the Inflammatory Response to One-lung Ventilation</brief_title>
  <official_title>Effects of Intraoperative Continuous Airway Pressure (CPAP) on the Inflammatory Response of the Lung With Cancer Undergoing Lobectomy. A Randomised Placebo-controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Parc de Salut Mar</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Parc de Salut Mar</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized placebo-controlled trial studying the effects of intraoperative
      continuous airway pressure (CPAP) on the inflammatory response of the lung with cancer
      undergoing lobectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pulmonary lobectomy induces an inflammatory response of this lung caused by intraoperative
      atelectasis and re-expansion. This inflammatory response can be attenuated with treatment,
      also decreasing postoperative pulmonary complications (PPC). Thus, avoiding complete
      atelectasis with partial insufflation of the lung during surgery could be useful to decrease
      inflammatory response and PPC.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Anticipated">October 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Alveolar and plasmatic cytokines measured before and after atelectasis and re-expansion.</measure>
    <time_frame>From preoperative to postoperative (24h) period.</time_frame>
    <description>Alveolar and plasmatic cytokines measured before and after atelectasis and re-expansion.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Alveolar MICA</measure>
    <time_frame>From preoperative to postoperative period (24h)</time_frame>
    <description>Alveolar MICA I (major histocompatibility complex (MHC) class I chain related genes) expression measured at the same control times.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CT-Scan</measure>
    <time_frame>22-24h after surgery</time_frame>
    <description>Postoperative distribution of well-aerated, non aerated or poorly aerated lung volumes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pulmonary complications (PPC).</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 10 days.</time_frame>
    <description>PPC.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>CPAP (positive airway pressure)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>To evaluate if continuous positive airway pressure(CPAP) on the lung undergoing lobectomy can decrease the inflammatory response PPC (postoperative pulmonary complications).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control without CPAP</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>CPAP (Continuous airway pressure)</intervention_name>
    <description>To evaluate if continuous positive airway pressure (CPAP) on the lung undergoing lobectomy can decrease the inflammatory response and PPC.</description>
    <arm_group_label>CPAP (positive airway pressure)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults (18-80 aged) with American Society of Anesthesiologists physical status I-III,
             scheduled to undergo elective thoracic surgery with lung resection performed through
             thoracotomy, and requiring OLV (one lung ventilation)during surgery.

        Exclusion Criteria:

          -  Ongoing treatment with any dose of systemic or topical steroids, acute pulmonary or
             extrapulmonary infections (elevated C-reactive protein [CRP]), history of recurrent
             pneumothoraces, previous thoracic surgery.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital del Mar</name>
      <address>
        <city>Barcelona</city>
        <zip>08003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lluis Gallart, PhD</last_name>
      <phone>0034 93 2483350</phone>
      <email>Lgallart@parcdesalutmar.cat</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 24, 2011</study_first_submitted>
  <study_first_submitted_qc>June 7, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 8, 2011</study_first_posted>
  <last_update_submitted>October 17, 2016</last_update_submitted>
  <last_update_submitted_qc>October 17, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 18, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Parc de Salut Mar</investigator_affiliation>
    <investigator_full_name>Llu√≠s Gallart</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Lung Cancer</keyword>
  <keyword>CPAP</keyword>
  <keyword>PPC</keyword>
  <keyword>lobectomy</keyword>
  <keyword>One-lung ventilation</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

